1
                                                                 Exhibit 99.2

                               ADAC LABORATORIES
                            1992 STOCK OPTION PLAN,
                              AMENDED AND RESTATED


         1.      PURPOSES OF PLAN.  The purposes of this 1992 Stock Option Plan
of ADAC Laboratories (the "Plan") are to attract and retain the best available
personnel for positions of substantial responsibility, and to provide
additional incentives to key employees, officers, consultants and other persons
whose efforts are deemed worthy of encouragement in order to promote the growth
and success of the Company's business.

         2.      DEFINITIONS.  As used herein, the following definitions shall
apply:

                 (a)      "BOARD" shall mean the Board of Directors of the
Company.

                 (b)      "CODE" shall mean the Internal Revenue Code of 1986,
as amended.

                 (c)      "COMMON STOCK" shall mean the Common Stock of the
Company.

                 (d)      "COMPANY" shall mean ADAC Laboratories, a California
corporation.

                 (e)      "COMMITTEE" shall mean the Committee appointed by the
Board of Directors in accordance with Section 4(a) below, if one has been
appointed.

                 (f)      "CONSULTANT" shall mean any person who is engaged by
the Company or any Parent or Subsidiary of the Company to render consulting
services.

                 (g)      "CONTINUOUS STATUS AS AN EMPLOYEE OR CONSULTANT"
shall mean the absence of any interruption or termination of services as an
Employee or Consultant.  Continuous Status as an Employee or Consultant shall
not be considered interrupted in the case of sick leave, military leave, or any
other leave of absence approved by the Board, provided that either such leave
is for a period of not more than ninety (90) days or reemployment upon the
expiration of such leave is guaranteed by contract or statute.

                 (h)      "EMPLOYEE" shall mean any person, including an
officer or director, employed by the Company or any Parent or Subsidiary of the
Company.  The payment of a director's fee by the Company shall not be
sufficient to constitute "employment" by the Company.

                 (i)      "OFFICER" shall mean any person, including a
director, employed by the Company or any Parent or Subsidiary of the Company
who has been elected an officer of the Company by the Board





   2

ADAC Laboratories
1992 Stock Option Plan,
Amended and Restated


of Directors and who is required to file periodic reports under Section 16(a)
of the Securities Exchange Act of 1934.

                 (j)      "OPTION" or "OPTIONS" shall mean one or more stock
options issued pursuant to the Plan.  Options may be either "Incentive
Options," which are defined as Options intended to meet the requirements of
Section 422A of the Code and any regulations promulgated thereunder, or
"Nonqualified Options," which are defined as Options not intended  to meet such
requirements.

                 (k)      "OPTIONED STOCK" shall mean the Common Stock subject
to an Option.

                 (l)      "OPTIONEE" shall mean a person who receives an
Option.

                 (m)      "PARENT" shall mean a "parent corporation", whether
now or hereafter existing, as defined in Section 425(e) of the Code.

                 (n)      "PLAN" shall mean this 1992 Stock Option Plan.

                 (o)      "SHARE" shall mean a share of Common Stock, as may be
adjusted in accordance with Section 11 below.

                 (p)      "SUBSIDIARY" shall mean a "subsidiary corporation",
whether now or hereafter existing, as defined in Section 425(f) of the Code.

         3.      STOCK SUBJECT TO THE PLAN.  Subject to the provisions of
Section 11 and Section 4(b)(x) below, the maximum aggregate number of shares
that may be optioned and sold under the Plan is 3,801,000 shares of Common
Stock.  If an Option should expire or become unexercisable for any reason
without having been exercised in full, then the unpurchased shares that were
subject to the Option shall, unless the Plan has been terminated, become
available for future grant under the Plan.

         4.      ADMINISTRATION OF THE PLAN.

                 (a)      APPOINTMENT OF COMMITTEE.

                          (i)     Before any Option under the Plan is granted
                 to an Officer or Director of the Company, the Board shall
                 appoint a Committee, comprised of not less than two (2)
                 members of the Board, each of whom shall be a "disinterested
                 person", as that term is defined from time to time




                                       2
   3
ADAC Laboratories
1992 Stock Option Plan,
Amended and Restated




                 in Rule 16b-3 promulgated under the Securities Exchange Act of
                 1934, as amended, and, in addition, as may be further defined
                 under Section 162(m) of the Internal Revenue Code of 1986.
                 The Committee may be an existing committee of the Board or a
                 new committee organized for the purpose of administering the
                 Plan.  Options granted to any person who is both an employee
                 and a Director may be granted only by the Committee.

                          (ii)    An Option to an Officer may be granted by the
                 Board if each member thereof is then a "disinterested person"
                 (as hereinabove defined).  Otherwise, an Option to an Officer
                 may be granted only by the Committee.

                          (iii) A Option to a person who is neither an Officer
                 nor a Director may be granted by either the Board or the
                 Committee.

                          (iv)    Subject to the foregoing, the Board may, from
                 time to time, increase the size of the Committee and appoint
                 additional members thereof, remove members (with or without
                 cause) and appoint new members in substitution therefor, fill
                 vacancies however caused or remove all members of the
                 Committee.  All actions of the Board or the Committee, if
                 taken in accordance with the Company's Bylaws, shall be valid
                 notwithstanding the fact that one or more of the members
                 thereof do not constitute "disinterested persons", as
                 hereinabove defined.

                 (b)      POWERS OF THE BOARD.  Subject to the provisions of
the Plan, the Board and the Committee shall have the authority, in its
discretion:

                          (i)     to determine, upon review of relevant
                 information, the fair market value of the Common Stock;

                          (ii)    to determine the persons to whom Options
                 shall be granted, the time or times at which Options shall be
                 granted, the number of Shares to be represented by each Option
                 and the exercise price per Share;

                          (iii) to interpret the Plan;

                          (iv)    to prescribe, adopt, amend, and rescind rules
                 and regulations relating to the Plan;





                                       3
   4
ADAC Laboratories
1992 Stock Option Plan,
Amended and Restated




                          (v)     to determine whether an Option granted shall
                 be an Incentive Option or a Nonqualified Option and to
                 determine the terms and provisions of each Option granted
                 (which need not be identical) and, with the consent of the
                 holder thereof, to modify or amend each Option;

                          (vi)    to determine the exercise date(s) and the
                 number of shares exercisable at each such date, and to
                 accelerate or defer (with the consent of the Optionee) the
                 exercise date of any Option;

                          (vii) to authorize any person to execute on behalf of
                 the Company any instrument required to effectuate the grant of
                 an Option previously approved by the Board or the Committee;

                          (viii)  to make such adjustments to Options granted
                 under the Plan to enable them to comply with the laws of
                 foreign jurisdictions and/or to make them consistent with
                 options customarily utilized by companies in foreign
                 jurisdictions;

                          (ix)    to make all other determinations deemed
                 necessary or advisable for the administration of the Plan.

                          (x)     Notwithstanding the number of shares set
                 forth in Section 3, the maximum aggregate number of shares
                 subject to the Plan may be automatically increased by the
                 Board, at its discretion and without shareholder approval, if
                 the Board determines in connection with an acquisition of
                 another business (whether by merger, consolidation or purchase
                 of assets or otherwise) that it is necessary to grant a
                 substantial number of new options to employees of, or persons
                 holding options in, such acquired business to replace existing
                 options, to grant new options to incentivize the employees or
                 replace other equity rights previously granted to such persons
                 by the acquired business.  The amount of the additional number
                 of shares to become subject to the Plan shall not exceed the
                 number of new options granted in connection with such
                 acquisition.

                 (c)      EFFECT OF DECISIONS.  All decisions, determinations,
and interpretations of the Board or the Committee shall be final and binding on
all Optionees and any other holders of any Options granted under the Plan.





                                       4
   5
ADAC Laboratories
1992 Stock Option Plan,
Amended and Restated




         5.      ELIGIBILITY; MAXIMUM ANNUAL LIMITATION.  Options may be
granted only to Employees, Officers, Consultants or other persons whose efforts
are deemed by the Board or the Committee to be  worthy of encouragement in
order to promote the growth and success of the Company.  A person who has been
granted an Option may, if he/she is otherwise eligible, be granted an
additional Option or Options.  Options under the Plan may not be granted to any
non-employee director.  The aggregate number of shares of Common Stock with
respect to which Options may be granted to any one Optionee shall not exceed
300,000 shares in any calendar year, subject to adjustment in accordance with
Section 11.

                 Neither the Plan nor any Option granted hereunder shall confer
upon any Optionee any right with respect to continuation of employment with the
Company, nor shall it interfere in any way with his/her right or the Company's
right to terminate his/her employment at any time, with or without cause.

         6.      TERM OF PLAN.  The Plan shall continue in effect for a term of
ten (10) years unless sooner terminated under Section 13 below.  Options may be
granted hereunder immediately.

         7.      TERM OF OPTION.  The term of any Incentive Option granted
under the Plan shall be for a period of not to exceed ten (10) years from the
date on which it is granted, as determined by the Board of Directors or the
Committee; provided, however, that any Incentive Option granted to any person
who owns shares possessing more than ten percent (10%) of the total combined
voting power or value of all classes of stock of the Company or of a Subsidiary
of the Company shall have a term of not to exceed five (5) years.  The term of
a Nonqualified Option shall be for a period of not to exceed ten (10) years
from the date on which it is granted, as determined by the Board of Directors
or the Committee.

         8.      EXERCISE PRICE AND CONSIDERATION.

                 (a)      EXERCISE PRICE.  The per share exercise price for the
Shares to be issued pursuant to the exercise of an Incentive Option shall not
be less than one hundred percent (100%) of the fair market value of the
Company's Common Stock on the date of grant as determined by the Board or the
Committee; provided, however, that any Incentive Option granted to any person
who owns shares possessing more than ten percent (10%) of the total combined
voting power or value of all classes of stock of the Company or of a Subsidiary
thereof shall have a per share exercise price of one hundred ten percent (110%)
of the fair market value of the Company's Common Stock on the date of grant as
determined by the





                                       5
   6
ADAC Laboratories
1992 Stock Option Plan,
Amended and Restated




Board or the Committee.  The per share exercise price for Shares to be issued
pursuant to the exercise of a Nonqualified Option shall not be less than one
hundred percent (100%) of the fair market value of the Company's Common Stock
on the date of grant as determined by the Board or the Committee.

                 (b)      FAIR MARKET VALUE.  The fair market value shall be
determined by the Board or the Committee in its discretion; provided, however,
that if there is a public market for the Common Stock, the fair market value
per Share shall be, in the event the Common Stock is listed on the NASDAQ
National Market System or on a stock exchange, the closing price on such
National Market System or exchange on the date of grant of the Option, as
reported in the "Wall Street Journal", and, if not so listed, fair market value
shall be the mean of the bid and asked prices of the Common Stock on the date
of the grant, as reported in the "Wall Street Journal" (or, if not so reported,
as otherwise reported by the National Association of Securities Dealers
Automated Quotation (NASDAQ) System).

                 (c)      CONSIDERATION.  The consideration to be paid for the
Shares to be issued upon exercise of an Option, including the method of
payment, shall be determined by the Board or the Committee and may consist
entirely of cash, check, promissory note or shares of Company Common Stock
(which must have been held for at least six (6) months) having a fair market
value on the date of surrender equal to the aggregate exercise price of the
Shares as to which the Option shall be exercised, or any combination of such
methods of payment, or other consideration and method of payment for the
issuance of Shares to the extent permitted under Section 408 and 409 of the
California General Corporation Law.  In making its determination as to the type
of consideration to accept, the Board or the Committee shall consider whether
such consideration may be reasonably expected to benefit the Company.

                 (d)      RE-LOAD OPTION.  Whenever an Optionee exercises an
Option by surrendering already-owned shares to pay all or a portion of the
exercise price, if the Option Agreement so provides or if permitted by the
Board or the Committee, at its discretion, at the time of such exercise, the
Optionee shall receive a new Option for the purchase of a number of Shares
equal to the number of Shares so surrendered, and such new Option shall have an
exercise price of not less than the fair market value of a Share of Common
Stock on the date of such surrender and shall vest and become exercisable as
may be determined by the Board or the Committee.





                                       6
   7
ADAC Laboratories
1992 Stock Option Plan,
Amended and Restated




                 (e)      WITHHOLDING TO PAY TAXES.  Option Agreements under
the Plan may contain a provision to the effect that all Federal and state taxes
required to be withheld or collected from an Optionee upon exercise of an
Option may be satisfied by either (i) delivering outstanding shares of Common
Stock of the Company previously owned for six (6) months by the Optionee or
(ii) the withholding of a sufficient number of exercised Option shares which,
valued at fair market value on the date of exercise, would be equal to the
total withholding obligation of the Optionee; provided, however, that no person
who is an "officer" of the Company, as such term is defined in Rule 3b-2 under
the Securities Exchange Act of 1934, may elect to satisfy the withholding of
Federal and state taxes upon the exercise of an Option by the withholding of
Optioned Stock unless such election is made either (i) at least six months
prior to the date that the exercise of the Option becomes a taxable event or
(ii) during any of the periods beginning on the third business day following
the date on which the Company releases publicly the operating results of a
fiscal quarter or fiscal year and ending on the twelfth (12th) business day
following such date.  Such election shall be deemed made upon receipt of notice
thereof by an officer of the Company, by mail, personal delivery or by
facsimile message, and shall be operative for all Option exercises which occur
following the election, until terminated by a notice revoking such withholding
election (such termination shall become effective six (6) months after the date
of such new notice).

         9.      EXERCISE OF OPTION.

                 (a)  PROCEDURE FOR EXERCISE; RIGHTS AS A SHAREHOLDER.

                          (i)     Any Option granted hereunder shall be
exercisable at such times and under such conditions as determined by the Board
or the Committee, including performance criteria with respect to the Company
and/or the Optionee, and as otherwise permissible  under the terms of the Plan.

                          (ii)    An Option may not be exercised for a fraction
of a Share.

                          (iii) An Option shall be deemed to be exercised when
written notice of such exercise has been given to the Company in accordance
with the terms of the Option by the person entitled to exercise the Option and
full payment for the Shares with respect to which the Option is exercised has
been received by the Company; provided, however, that the Board or the
Committee may prescribe and adopt rules and procedures allowing an Optionee to
exercise an Option and sell the Optioned Stock simultaneously (or on the same





                                       7
   8
ADAC Laboratories
1992 Stock Option Plan,
Amended and Restated




business day) under circumstances which provide reasonable certainty that the
Company will receive the Option exercise price by the settlement date of the
sale of the Optioned Stock.  Until the issuance (as evidenced by an appropriate
entry on the books of the Company or of a duly authorized transfer agent of the
Company) of the stock certificate evidencing such Shares, no right to vote or
receive dividends or any other rights as a shareholder shall exist with respect
to the Optioned Stock, notwithstanding the exercise of the Option.  No
adjustment shall be made for a dividend or other right for which the record
date is prior to the date the stock certificate is issued, except as provided
in Section 11 below.

                          (iv)    Exercise of an Option in any manner shall
result in a decrease in the number of Shares which thereafter may be available,
both for purposes of the Plan and for exercise under the Option, by the number
of Shares as to which the Option is exercised.

                 (b)      TERMINATION OF CONTINUOUS STATUS AS AN EMPLOYEE OR
CONSULTANT.

                          (i)     Except as set forth in Section 9(b)(ii)
below, if an Employee or Consultant ceases his/her Continuous Status as an
Employee or Consultant (as the case may be), he/she may, but only within ninety
(90) days (or, with respect to Nonqualified Options, such longer period of time
as may be determined by the Board or the Committee), after the date he/she
ceases to have such Continuous Status, exercise his/her Option to the extent
that he/she was entitled to exercise it at the date of such termination.

                          (ii)    Notwithstanding the provisions of Section
9(b)(i) above, if the holder of an Option (A) is terminated due to Optionee's
willful refusal to perform the normal and/or reasonable duties and
responsibilities delegated to Optionee as an Employee of the Company, (B) is
terminated due to Optionee's expropriation of Company property (including trade
secrets or other proprietary rights), or (C) leaves the employment of the
Company in order to directly (or indirectly, as an employee or agent of another
business or business entity) compete with the Company, the Board or the
Committee shall have the authority, by notice to the holder of an Option, to
immediately terminate such Option, effective on the date of termination, and
such Option shall no longer be exercisable to any extent whatsoever.

                 (c)      RETIREMENT.  Notwithstanding the provisions of
Section 9(a) above, if an Optionee ceases Continuous Status as an





                                       8
   9
ADAC Laboratories
1992 Stock Option Plan,
Amended and Restated




Employee or Consultant as a result of retiring as an active Employee or
Consultant of the Company at age 62 or older, such ninety-day period shall be
extended to one (1) year.  To the extent that Optionee was not entitled to
exercise the Option at the date of such termination, or if Optionee does not
exercise such Option within the time specified herein, the Option shall
terminate.


                 (d)      DISABILITY.  Notwithstanding the provisions of
Section 9(a) above, in the event an Employee or Consultant is unable to
continue his/her employment or consulting relationship (as the case may be)
with the Company as a result of his/her total and permanent disability (as
defined in Section 105(d)(4) of the Code), he/she may, but only within a period
of up to twenty-four (24) months (or such shorter or longer period of time as
is determined by the Board or the Committee or as set forth in the Option
Agreement) from the date of termination, exercise the Option to the extent
Optionee was entitled to exercise it at the date of such termination.  To the
extent that Optionee was not entitled to exercise the Option at the date of
termination, or if Optionee does not exercise such Option within the time
specified herein, the Option shall terminate.

                 (e)      DEATH OF OPTIONEE.  In the event of the death of an
Optionee which occurs during the time in which an Option may be exercised, such
Option may be exercised at any time within two (2) years following the date of
death or such shorter period as may be set forth in the Option Agreement, by
the Optionee's estate or by a person who acquired the right to exercise the
Option by bequest or inheritance, but only to the extent of the right to
exercise that would have accrued had the Optionee continued living and remained
in Continuous Status as an Employee or Consultant for two (2) years after the
date of death.

                 (f)      DESIGNATION OF BENEFICIARY.  Notwithstanding anything
in the Plan to the contrary, any Option Agreement issued under the Plan may
provide for the designation of a beneficiary of the Optionee (which may be an
individual or a trust) who may exercise the Option after the Optionee's death
and enjoy the economic benefits thereof, subject to the consent of Optionee's
spouse if required by law.

         10.     NON-TRANSFERABILITY OF OPTIONS.

                 Options shall not be transferable by the holder thereof
otherwise than (i) by will, (ii) pursuant to the laws of descent and
distribution or (iii) pursuant to a dissolution of marriage, whether pursuant
to a qualified domestic relationship order,





                                       9
   10
ADAC Laboratories
1992 Stock Option Plan,
Amended and Restated




stipulation between the optionholder and spouse or otherwise; provided,
however, that an Optionee may designate a beneficiary who, upon Optionee's
death, may exercise the Option to the extent permitted in Section 9 of the
Plan.

         11.     ADJUSTMENTS.

                 (a)      STOCK SPLITS, DIVIDENDS AND OTHER COMBINATIONS.
Subject to any required action by the shareholders of the Company, the number
of shares of Common Stock covered by each outstanding Option, and the number of
shares of Common Stock which have been authorized for issuance under the Plan
but as to which no Options have yet been granted or which have been returned to
the Plan upon cancellation or expiration of an Option, as well as the price per
share of Common Stock covered by each such outstanding Option, shall be
proportionately adjusted for any increase or decrease in the number of issued
shares of Common Stock resulting from a stock split, reverse stock split, stock
dividend, combination or reclassification of the Common Stock, or any other
increase or decrease in the number of issued shares of Common Stock effected
without receipt of consideration by the Company; provided, however, that
conversion of any convertible securities of the Company shall not be deemed to
have been "effected without receipt of consideration."  Such adjustment shall
be made by the Board or the Committee, whose determination in that respect
shall be final, binding and conclusive.  Except as expressly provided herein,
no issuance by the Company of shares of stock of any class, or securities
convertible into shares of stock of any class, shall affect, and no adjustment
by reason thereof shall be made with respect to, the number or price of shares
of Common Stock subject to an Option.

                 (b)      DISSOLUTION OR LIQUIDATION.  In the event of the
proposed dissolution or liquidation of the Company, each Option shall terminate
immediately prior to the consummation of such proposed action, unless otherwise
provided by the Board or the Committee.  The Board or the Committee may, in the
exercise of its sole discretion in such instances, declare that any Option
shall terminate as of a date fixed by the Board or the Committee and give each
Optionee the right to exercise his/her Option as to all or any part of the
Optioned Stock, including Shares as to which the Option would not otherwise be
exercisable.

                 (c)      SALE OF ASSETS OR MERGER.  In the event of a proposed
sale of all or substantially all of the assets of the Company, or the merger of
the Company with or into another corporation, the Option shall be assumed or an
equivalent option





                                       10
   11
ADAC Laboratories
1992 Stock Option Plan,
Amended and Restated




(containing the same vesting schedule and equivalent exercise price) shall be
substituted by such successor corporation or a parent or subsidiary of such
successor corporation, unless the Board or the Committee determines, in the
exercise of its sole discretion and in lieu of such assumption or substitution,
that the Optionee shall have the right to exercise the Option as to all of the
Optioned Stock, including Shares as to which the Option would not otherwise be
exercisable.  If the Board or the Committee makes an Option fully exercisable
in lieu of assumption or substitution in the event of a merger or sale of
assets, then the Board shall notify the Optionee that the Option shall be fully
exercisable for a period of thirty (30) days from the date of such notice, and
the Option shall terminate upon the expiration of such period.

                 (d)      CHANGE IN CONTROL.

                          (i)     Except and to the extent provided otherwise
in, or limited by, employment, severance or similar written agreements between
the Company and an Optionee, ten (10) days prior to a "Change in Control" (as
defined below), all stock options which are then not exercisable shall
immediately vest and become exercisable, regardless of the original vesting
schedule.  A "Change in Control" of the Company shall be deemed to have
occurred if (a) any "person" or "group" (as defined in or pursuant to Sections
13(d) or 14(d) of the Securities Exchange Act of 1934, as amended (the
"Exchange Act")), becomes the "beneficial owner" (as defined in Rule 13d-3
promulgated under the Exchange Act), directly or indirectly, of securities of
the Company representing 40% or more of the voting power of the common stock
outstanding which votes generally for the election of directors; (b) as a
result of market or corporate transactions or shareholder action, the
individuals who constitute the Board of Directors of the Company at the
beginning of any period of 12 consecutive months (but commencing not earlier
than July 1, 1995), plus any new directors whose election or nomination was
approved by a vote of at least two-thirds of the directors still in office who
were directors at the beginning of such period of 12 consecutive months, cease
for any reason during such period of 12 consecutive months to constitute at
least two-thirds of the members of such Board; or (c) the Company sells,
through merger, assignment or otherwise, in one or more transactions other than
in the ordinary course of business, assets which provided at least 2/3 of the
revenues or pre-tax net income of the Company and its subsidiaries on a
consolidated basis during the most recently-completed fiscal year.

                          (ii)  Notwithstanding paragraph (i) above, the 
following events shall not constitute a Change in Control:  any





                                       11
   12
ADAC Laboratories
1992 Stock Option Plan,
Amended and Restated




acquisition of beneficial ownership pursuant to (a) a reclassification, however
effected, of the Company's authorized common stock, or (b) a corporate
reorganization involving the Company or any of its subsidiaries which does not
result in a material change in the ultimate ownership by the shareholders of
the Company (through their ownership of the Company or its successor resulting
from the reorganization) of the assets of the Company and its subsidiaries, but
only if such reclassification or reorganization has been approved by the
Company's Board of Directors.

         12.     SPECIAL PROVISIONS RELATING TO INCENTIVE OPTIONS.  The Company
shall not grant Incentive Options under the Plan to any Optionee to the extent
that the aggregate fair market value of the Common Stock covered by such
Incentive Options which are exercisable for the first time during any calendar
year, when combined with the aggregate fair market value of all stock covered
by incentive stock options granted to such Optionee after December 31, 1986 by
the Company, its Parent or a Subsidiary thereof which are exercisable for the
first time during the same calendar year, exceeds $100,000.  Incentive Options
shall be granted only to persons who, on the date of grant, are Employees of
the Company or a Parent or a Subsidiary of the Company.  Notwithstanding the
above, to the extent the fair market value of Shares subject to Incentive Stock
Options first exercisable in a calendar year is greater than $100,000, the
excess Options shall be treated as Non-qualified Options.

         13.     AMENDMENT AND TERMINATION OF THE PLAN.

                 (a)      AMENDMENT AND TERMINATION.  The Board or the
Committee may at any time suspend, amend or terminate the Plan with or without
shareholder approval; provided, however, that if the Plan has been previously
approved by the shareholders, no amendment or modification may be adopted
without shareholder approval if the amendment would (i) materially increase the
benefits accruing to participants under the Plan; (ii) materially increase the
number of Shares which may be issued under the Plan or (iii) materially modify
the requirements as to the eligibility for participation in the Plan.

                 (b)      EFFECT OF AMENDMENT OR TERMINATION.  Any such
amendment or termination of the Plan shall not affect Options already granted
and such Options shall remain in full force and effect as if the Plan had not
been amended or terminated, unless mutually agreed otherwise between the
Optionee and the Board or the Committee, which agreement must be in writing and
signed by the Optionee and the Company.





                                       12
   13
ADAC Laboratories
1992 Stock Option Plan,
Amended and Restated





         14.     CONDITIONS UPON ISSUANCE OF SHARES.

                 (a)      COMPLIANCE WITH SECURITIES LAWS.  Shares shall not be
issued pursuant to the exercise of an Option unless the exercise of such Option
and the issuance and delivery of such Shares pursuant thereto complies with all
relevant provisions of law, including, without limitation, the Securities Act
of 1933, the Securities Exchange Act of 1934, the rules and regulations
promulgated thereunder, and the requirements of any stock exchange upon which
the Shares may then be listed.  The exercise of such Option and the issuance
and delivery of such Shares pursuant thereto shall be further subject to the
approval of counsel for the Company with respect to such compliance.

                 (b)      INVESTMENT REPRESENTATION.  As a condition to the
exercise of an Option, the Company may require the person exercising such
Option to represent and warrant at the time of any such exercise that the
Shares are being purchased only for investment and without any present
intention to sell or distribute such Shares if, in the opinion of counsel for
the Company, such a representation is required by any of the aforementioned
relevant provisions of law.

         15.     RESERVATION OF SHARES.  The Company, during the term of the
Plan, will at all times reserve and keep available such number of Shares as
shall be sufficient to satisfy the requirements of the Plan.  The inability of
the Company to obtain authority from any regulatory body having jurisdiction,
which authority is deemed by the Company's counsel to be necessary to the
lawful issuance and sale of any Shares hereunder, shall relieve the Company of
any liability in respect of the failure to issue or sell such Shares as to
which such requisite authority shall not have been obtained.

         16.     OPTION AGREEMENTS.  Options shall be evidenced by written
Option Agreements in such form as the Board or the Committee shall approve.

         17.     SHAREHOLDER APPROVAL.  The Plan shall become effective when
approved by the Board or any committee thereof having authority to do so and
the shareholders of the Company. 


                                                   Adopted and Approved
                                                   Effective July 8, 1992





                                       13